XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash Flows From Operating Activities:    
Net loss $ (16,786,274) $ (12,269,341)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 1,925,602 619,544
Issuance of common stock for services 273,884 68,000
Amortization of operating lease right-of-use asset 86,619 80,112
Depreciation 1,461 305
Changes in operating assets and liabilities:    
Prepaid expenses 238,295 (1,154,792)
Deposits 19,031
Accounts payable 428,033 (723,358)
Accrued expenses 714,669 76,570
Accrued compensation (1,112,750) (482,544)
Accrued interest 7,907
Operating lease liability (86,253) (77,315)
Net Cash Used In Operating Activities (14,316,714) (13,835,881)
Cash Flows From Financing Activities:    
Proceeds from sale of NoveCite, Inc. common stock 500
Net proceeds from private placement 18,450,410
Net proceeds from registered direct offering 70,979,842
Net proceeds from common stock warrant exercises 14,242,543
Net Cash Provided By Financing Activities 103,673,295
Net Change in Cash and Cash Equivalents (14,316,714) 89,837,414
Cash and Cash Equivalents - Beginning of Period 70,072,946 13,859,748
Cash and Cash Equivalents - End of Period $ 55,756,232 $ 103,697,162